50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today AEMD ranks #10370 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$2.63 (-2.23%)

Volume: 127k

Closed: Nov 26, 2021

Hollow Logo Score: -3.116

Aethlon Medical Stock Forecast

$2.63 (-2.23%)

Volume: 127k

Closed: Nov 26, 2021

Score Hollow Logo -3.116
Which way will AEMD go? Request
Key Stats
Beta -0.18
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 26 and the stock is currently not being overbought or oversold

Aethlon Medical stock price down 2.23% on Friday
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-26

The Aethlon Medical stock price fell by -2.23% on the last day (Friday, 26th Nov 2021) from $2.69 to $2.63. During the day the stock fluctuated 5.14% from a day low at $2.53 to a day high of $2.66. The price has fallen in 8 of the last 10 days and is down by -11.15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 127 thousand shares were bought and sold for approximately $334.02 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.47 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -19.96% during the next 3 months and, with a 90% probability hold a price between $1.97 and $3.43 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 5.20%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aethlon Medical stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.66 and $3.22. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

Aethlon Medical finds support from accumulated volume at $2.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 5.14%. For the last week the stock has had a daily average volatility of 7.63%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Aethlon Medical stock A Buy?

Aethlon Medical holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.116

Predicted Opening Price for Aethlon Medical of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$2.61 $2.63 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 10, 2021 "HC Wainwright" gave "$9.00" rating for AEMD. The price target was changed from $5.00 to 4.9%.

Volatility and Risk
Daily Average Volatility: 7.63 %
Overall Risk: Very High High Medium Low Very Low
7.63 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $3.05
Price: $2.63
Support: $2.54

AEMD Insider Trading Show all Trades



Last 100 transactions
Buy: 2 084 745 | Sell: 236 064 (Shares)
Date Action Amount Person Type
Sep 30, 2021 Sell 2 430 Broenniman Edward G Common Stock
Sep 30, 2021 Sell 2 430 Johnson Sabrina Martucci Common Stock
Sep 30, 2021 Sell 2 430 Shah Chetan Common Stock
Jun 30, 2021 Sell 2 430 Johnson Sabrina Martucci Common Stock
Jun 30, 2021 Sell 2 430 Shah Chetan Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 2 084 745 | Sell: 236 064 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 2.74 4.06 %
2.69 2.17 %
2.66 1.00 %
Current price: 2.63
Support 2.56 -2.78 %
2.53 -3.94 %
2.48 -5.83 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 3.12 18.63 %
3.07 16.73 %
3.05 15.97 %
Current price 2.63
Support 2.54 -3.42%
2.50 -4.94%
0 .

Click to get the best stock tips daily for free!

About Aethlon Medical

Aethlon Medical Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE